(Q37936433)

25 August 2017

1 reference

title

Antiprogesterone RU 486--a drug for non-surgical abortion (English)

1 reference

25 August 2017

0 references

Heikinheimo O

1

1 reference

25 August 2017

Ylikorkala O

series ordinal

2

1 reference

25 August 2017

Lähteenmäki P

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 April 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

22

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

75-84

1 reference

Plasma concentrations and receptor binding of RU 486 and its metabolites in humans

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Differences in the association of the progesterone receptor ligated by antiprogestin RU38486 or progestin ORG 2058 to chromatin components

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Glucocorticoid receptors bound to the antagonist RU486 are not downregulated despite their capacity to interact in vitro with defined gene regions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Contraceptive potential of RU 486 by ovulation inhibition: II. Suppression of pituitary gonadotropin secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Progestins inhibit FSH-stimulated steroidogenesis in cultured rat granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Effects of the antiglucocorticoid RU 486 on adrenal function in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

The antiglucocorticoid and antiprogestin steroid RU 486: its glucocorticoid agonist effect is inadequate to prevent adrenal insufficiency in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

Distribution of RU 486 and its demethylated metabolites in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899009147247

10.3109/07853899009147247

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference